Related Experiment Video
Updated: Jun 8, 2026

08:26
Isolation and Culture of Adult Epithelial Stem Cells from Human Skin
Published on: March 31, 2011
Recent progress in dyskeratosis congenita.
Nobuhiro Nishio1, Seiji Kojima
1Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, 466-8550, Japan.
International Journal of Hematology
|October 1, 2010
Summary
Dyskeratosis congenita (DC) involves short telomeres, leading to various health issues. Defective telomere maintenance causes DC and other diseases, broadening the concept of telomere shortening syndromes.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Dyskeratosis congenita (DC) is an inherited disorder characterized by nail dystrophy, skin pigmentation abnormalities, oral leukoplakia, bone marrow failure, and cancer predisposition.
- DC is fundamentally a disease of impaired telomere maintenance, resulting in critically short telomeres in affected individuals.
- Mutations in six genes related to telomerase and telomere components have been identified in DC patients.
Purpose of the Study:
- To explore the broader implications of defective telomere maintenance beyond classical Dyskeratosis congenita.
- To introduce the concept of
Main Methods:
- Literature review of genetic mutations in telomere biology.
- Analysis of clinical manifestations in patients with short telomeres.
Main Results:
- Mutations in telomerase and telomere components are also found in patients with aplastic anemia, pulmonary fibrosis, and liver diseases without mucocutaneous symptoms.
- These findings suggest that defective telomere maintenance underlies a wider spectrum of diseases than previously recognized.
- This expands the understanding of diseases related to telomere shortening.
Conclusions:
- Defective telomere maintenance is implicated in both classical DC and a range of other idiopathic diseases.
- The concept of "syndromes of telomere shortening" unifies these conditions.
- Understanding telomere biology is crucial for diagnosing, counseling, and managing these diverse patient groups.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Desmosomes
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein complexes comprising desmosomal...
Renewal of Skin Epidermal Stem Cells
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
